Xenon Pharmaceuticals (XENE) Receivables - Other (2019 - 2026)
Xenon Pharmaceuticals (XENE) posted quarterly Receivables - Other of $1.2 million for Q1 2026, down 83.77% year-over-year from $7.2 million in Q1 2025, and up 108.41% quarter-over-quarter from $559000.0 in Q4 2025.
Xenon Pharmaceuticals (XENE) Receivables - Other (2019 - 2026) Analysis & Trends
Xenon Pharmaceuticals (XENE) has reported Receivables - Other for 4 consecutive years, with $1.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Receivables - Other fell 83.77% year-over-year to $1.2 million; the TTM figure through Mar 2026 stood at $1.2 million (changed N/A YoY), while the FY2025 annual figure was $1.4 million, down 6.67% from the prior year.
- Receivables - Other rose to $1.2 million in Q1 2026 per XENE's latest filing, from $559000.0 in the prior quarter.
- Across five years, Receivables - Other topped out at $7.2 million in Q1 2025 and bottomed at $83000.0 in Q3 2024.
- Historically, Receivables - Other has averaged $1.6 million across 3 years, with a median of $812000.0 in 2025.
- Annual changes were most pronounced in 2025 — Receivables - Other jumped 878.31% — and 2026, when it plunged 83.77%.
- Xenon Pharmaceuticals' Receivables - Other stood at $547000.0 in 2024, then grew by 2.19% to $559000.0 in 2025, then surged by 108.41% to $1.2 million in 2026.
- Business Quant data shows XENE's Receivables - Other at $1.2 million in Q1 2026, $559000.0 in Q4 2025, and $812000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Xenon Pharmaceuticals | 6.03 Bn | 6.03 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.63 Mn |
| Jun 30, 2026 | 1.63 Mn |
| Mar 31, 2026 | 1.17 Mn |
| Mar 31, 2026 | 1.17 Mn |
| Dec 31, 2025 | 559,000.00 |
| Dec 31, 2025 | 559,000.00 |
| Sep 30, 2025 | 812,000.00 |
| Sep 30, 2025 | 812,000.00 |
| Jun 30, 2025 | 1.10 Mn |
| Jun 30, 2025 | 1.10 Mn |
| Mar 31, 2025 | 7.18 Mn |
| Mar 31, 2025 | 7.18 Mn |
| Dec 31, 2024 | 547,000.00 |
| Dec 31, 2024 | 547,000.00 |
| Sep 30, 2024 | 83,000.00 |
| Sep 30, 2024 | 83,000.00 |
| Dec 31, 2019 | 448,000.00 |
| Dec 31, 2019 | 448,000.00 |